Merck
MRK
3,554 hedge funds and large institutions have $242B invested in Merck in 2024 Q2 according to their latest regulatory filings, with 180 funds opening new positions, 1,609 increasing their positions, 1,367 reducing their positions, and 119 closing their positions.
51% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 119
25% more capital inflows, than outflows
Capital inflows: $10.5B | Capital outflows: $8.42B
20% more call options, than puts
Call options by funds: $1.96B | Put options by funds: $1.64B
18% more repeat investments, than reductions
Existing positions increased: 1,609 | Existing positions reduced: 1,367
0.26% more ownership
Funds ownership: 76.97% → 77.23% (+0.26%)
0% more funds holding
Funds holding: 3,546 → 3,554 (+8)
20% less funds holding in top 10
Funds holding in top 10: 242 → 193 (-49)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$631M |
| 2 |
Alphinity Investment Management
Sydney,
Australia
|
+$517M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$499M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$421M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$378M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.79B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$633M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$448M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$354M |
| 5 |
HRT Financial
New York
|
-$203M |
MRK Hedge Fund Activity: Q2 2024 in Review
3,554 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2024, worth a combined $242B — down 5.7% from $257B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new MRK positions and 119 closed out — a net gain of 61 holders — while 1,609 added to existing stakes and 1,367 trimmed.
The largest buyer was UBS AM, adding an estimated $631M. The largest seller was Wellington Management Group, cutting an estimated $1.79B.
- 3,554 institutional investors held Merck (MRK) as of Q2 2024, up from 3,546 in Q1 2024.
- Funds reported $242B of Merck stock for Q2 2024, down 5.7% quarter-over-quarter.
- 180 funds opened new Merck positions in Q2 2024 and 119 closed out, a net change of +61 holders.
- The largest Merck buyer in Q2 2024 was UBS AM, an estimated $631M added.
- The largest Merck seller in Q2 2024 was Wellington Management Group, an estimated $1.79B sold.
Based on aggregated 13F filings for Q2 2024.